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INTRODUCTION
Middle ear cholesteatoma is characterized by keratinocytic hyper-
proliferation with bony destruction and granulation tissue by chron-
ic inflammation. The pathogenesis of middle ear cholesteatoma
has been debated for a century, but there are four basic theories:
invagination, basal cell hyperplasia, epithelial ingrowth and squa-
mous metaplasia.
During last century, etiopathogenicity of middle ear cholestea-
toma raised many controversies and still a unanimous concept
doesn’t exist. From a histological point of view this pathological
tissue is composed of 2 integrated parts - matrix and perimatrix.
The interaction between cellular components is essential for the
major histopathological features of cholesteatoma - hyperprolif-
eration and bone destruction. In 1964, the American anatomist
Gray referred to middle ear cholesteatoma as “skin in the wrong
place” (1). This simplified misdefinition stuck into literature and
has been cited profusely in many scientific papers. The metapla-
sia theory (2) and existence of so-called “congenital” cholesteatoma
put into question the “skin origin” of middle ear cholesteatoma
and gave etiopathogenetical evidences against the simplified
definition “skin in the wrong place”. The list of histological dif-
ferences includes the absence of cutaneous adnexa and special-
ized dermal structures. Neither hypodermal structures, nor blood
vessels, or nerve endings have been ever described in choleste-
atoma. The only similarity that is left between them is the pres-
ence of multistratified squamous epithelium, but in cholesteatoma
this epithelium is with hyperproliferative properties.
Experimental models are critical for studying pathogenesis of
middle ear cholesteatoma. In vivo models were tried to establish
by chemical injection into the middle ear (3), ligation of exter-
nal auditory canal (4) and transplantation of skin (5). Keratinocytes
of middle ear cholesteatoma were cultured by tissue culture (6),
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passaged subculture (7) and air-liquid interface system (8). How-
ever, stable experimental models of middle ear cholesteatoma
are not established until now. Our study has aimed to create an
“adequate” in vitro model, based on the cell-to-cell interaction
between keratinocytes and fibroblasts and to assess the grade
of homogeneity between cholesteatoma and skin keratinocytes
by focusing on the cytokeratin profile.
MATERIALS AND METHODS
Cell culture
Enzymatic disaggregation protocol for simultaneous isolation of
primary keratinocytes and fibroblasts from cholesteatoma tissue
has been developed. The biopsy samples were harvested from
patients undergoing surgical treatment in the Department of Oto-
laryngology, Ajou University Hospital, Korea. An informed con-
sent form approved by the Institutional Review Board of Ajou
University Hospital was signed by each patient. Cholesteatoma
keratinocytes were cultured in Defined Keratinocytes Serum Free
Medium (GIBCO, BRL, Gaithersburg, MD, USA) supplied with
growth supplement and 5 mg/mL Gentamicin (GIBCO, BRL)
according to the manufacture instructions. Cholesteatoma pri-
mary fibroblasts were successfully cultured in Dulbeco Modified
Eagle Medium (GIBCO, BRL) supplemented with 10% Fetal
Bovine Serum (FBS, Clonetics, Walkersville, MD, USA) and 1%
Penicillin-Streptomycin mixture (GIBCO, BRL). Primary ker-
atinocytes (passage 1) and fibroblasts (between passages 1-5)
were used for establishment of the co-cultured system. HaCaT
cell line was kindly provided from the Department of Dermatology
in Ajou University Hospital. Feeder layer from cholesteatoma
fibroblasts was developed using pretreatment with Mitomycin C
(Sigma, St. Louis, MO, USA) in concentration 0.25 g/mL. Fibro-
blasts were incubated overnight at 37℃, 5% CO2 in humidified
atmosphere. On the next day the media was exchanged and the
cells were incubated additionally for another 24 hr. The feeder
layer was subsequently trypsinized from the substrate and
transferred on polyester membrane in Transwell (Costar, Cam-
bridge, MA, USA) system to develop a subconfluent feeder
layer. Feeder layer was incubated for 24-48 hr prior co-cultur-
ing. Cholesteatoma keratinocytes and HaCaT cells were seeded
at density 2×10
5 cells/mL over the feeder layer, co-cultured for
3-5 days and air-exposed for a period of 14 days. Two alterna-
tive models were elaborated using primary cholesteatoma ker-
atinocytes and HaCaT cells (Fig. 1). The control group was pre-
pared without feeder layer.
Morphological study
Transwell membranes were fixed in 4% formaldehyde overnight
at 4℃, dehydrated in graded alcohols, cleared in HistoClear
(National diagnostics, Atlanta, Georgia) and embedded in paraf-
fin. Six  m-thick sections were prepared and subjected to rou-
tine hematoxylin-eosin staining. 
Protein profile
Polyacrylamide gel electrophoresis has been used for protein
separation and staining with Coomassie blue was performed to
compare the protein profile between cholesteatoma keratinocytes
and HaCaT cells.
Cytokeratin profile
After separation, the proteins were transferred to a nitrocellulose
membrane. Blocking of nonspecific staining was accomplished with
membrane incubation with 5% non-fat skim milk for 1 hr at room
temperature (RT). Membranes were then incubated with primary
mouse monoclonal anti-cytokeratin antibody clone K 8.12 (Sigma)
which is immunospecific for cytokeratin 13 (CK 13) and cytok-
eratin 16 (CK 16), with dilution factor 1:100, for 1 hr at RT. After
washing membranes were incubated with goat anti-mouse horse-
radish peroxidase conjugate (Zymed, San Francisco, CA, USA).
The positive reaction was visualized with ECL Western Blotting
Detection System (Amersham, Bucks, UK).
Immunohistochemistry (IHC)
The localization of cytokeratin 13 and 16 in middle ear cholestea-
toma tissue was accomplished by IHC study as described before
(9). Five middle ear cholesteatoma samples were compared with
the corresponding retroauricular skin samples obtained during
surgery. Six  m thick formalin-fixed paraffin-embedded tissue
sections were processed with ABC-method. Samples were deparaf-
finized in xylene and rehydrated in alcohol. Heat-induced anti-
gen retrieval procedure was applied for antigen unmasking.
Fig. 1. Schematic illustrations of air-liquid interface system. (A) Middle ear cholesteatoma (MECh) keratinocytes are co-cultured with fibroblast
feeder layer. (B) Alternative model with HaCaT cells is used as a control group. Upper cellular surface is exposed to the air, and the media are
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Primary mouse monoclonal anticytokeratin antibody (Sigma) at
concentration 1:20 was incubated overnight at RT. Vectorlab
Elite ABC kit (Vector Laboratories, Burlingame, CA, USA ) was




Enzymatic disaggregation protocol yield a high number of sepa-
rated cells. The low selectivity and potential damages of cells in
case of prolonged incubation were major disadvantages of the
procedure. As an inflammatory tissue, cholesteatoma posed some
difficulties in isolation of primary keratinocytes, because of the
attendant inflammation and possible contamination, which requires
an adequate decontamination. The first primary keratinocytes
appeared usually 7-10 days after trypsinization and generally
within the next 10 days keratinocytes reached a confluence. The
individual variations in proliferative activity of cholesteatoma
keratinocytes were related to cholesteatoma localization and
sex of the patient. For instance, attic cholesteatoma frequently
resulted in isolation of primary keratinocytes with bigger prolif-
erative ability. Another interesting correlation was the fact that
cholesteatoma samples obtained from young female patients
were characterized by higher proliferative activity in vitro. The
above-mentioned dependencies were not statistically significant.
Primary cholesteatoma keratinocytes were uniform in shape and
arranged in a typical monolayer pattern (Fig. 2A). In passage 2
an abrupt deceleration in proliferation was established, accom-
panied by morphological alterations such as enlargement and
flattening of the cells, as well as vacuolization of the cytoplasm.
In passage 3 cells were practically incapable of proliferation. Pri-
mary cholesteatoma fibroblasts were steadily maintained with-
out significant changes of doubling time until passage 10. Primary
cholesteatoma fibroblasts displayed typical spindle-shaped mor-
phology upon confluence (Fig. 2B). No spontaneous transforma-
tion was detected in any of the cultures.
Fig. 2. (A) Confluent monolayer of primary middle ear cholesteatoma (passage I) keratinocytes shows a polygonal appearance. (B) Primary middle
ear cholesteatoma fibroblasts show typical spindle-shaped morphology (passage 1) upon reaching a confluence. Original magnification ×400.
A B
Fig. 3. Light microscopic observation on 3D-in vitro middle ear cholesteatoma model developed without fibroblasts (A) and in the co-cultured sys-
tem with middle ear cholesteatoma fibroblasts (B). Middle ear cholesteatoma keratinocytes show bigger stratification and increased cellular size in
the presence of fibroblasts. Hematoxylin-eosin staining, Original magnification ×400.
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Air-liquid interface (ALI)
Bigger stratification and proliferation have been observed in the
proposed 3D in vitro system when primary cholesteatoma ker-
atinocytes were co-cultured in the presence of fibroblasts (Fig. 3B)
in comparison with the control group without fibroblasts (Fig.
3A). Similar morphological landmarks were established in the
control group of HaCaT cells (Fig. 4A). Disrupted differentiation
in the suprabasal layers was revealed when cholesteatoma ker-
atinocytes were air-exposed in the presence of fibroblasts mim-
icking the parakeratosis state, which is typical for this patholog-
ical tissue in vivo (Fig. 4B).
Protein and cytokeratin profile
Coomassie blue staining of the protein extracts from primary
cholesteatoma keratinocytes and HaCaT cells revealed signifi-
cantly different protein profiles (Fig. 5A). Stronger expression of
CK 16 (48 kDa) and CK 13 (51 kDa) was established in cholestea-
toma keratinocytes in comparison with HaCaT cells (Fig. 5B).
Immunohistochemistry
Using mouse monoclonal antibody clone K 8.12, tissue localiza-
tion of CK 13 and CK 16 was verified both in the basal and
suprabasal layers of cholesteatoma (Fig. 6). The described stain-
ing patterns were established in all 5 cholesteatoma samples.
Fig. 4. Light microscopic observation on the alternative 3D-in vitro model utilizing HaCaT cells cultured without fibroblasts (A) and air-exposed
co-cultured system in the presence of middle ear cholesteatoma fibroblasts (B). HaCaT cells show bigger stratification when co-cultured with fibrob-
lasts. Hematoxylin-eosin staining, Original magnification ×400.
A B
Fig. 5. Comparative study on total protein profile
(A) and cytokeratin profile (B) between primary
middle ear cholesteatoma (MECh) keratinocytes
and HaCaT cells. Middle ear cholesteatoma ker-
atinocytes show different protein profile (arrows)
in comparison with HaCaT cells. Blotting with anti-
cytokeratin antibody shows the expression of cyto-
keratin 13 and 16 in both middle ear cholestea-












Fig. 6. Immunohistochemical observation on cytokeratin 13 and 16
expression in middle ear cholesteatoma tissue. Cytokeratin 13 and 16
are markers of active proliferative keratinocytes. Immunolabeling shows
the expression of them in the whole layer of middle ear cholesteatoma.90 Clinical and Experimental Otorhinolaryngology  Vol. 1, No. 2: 86-91, June 2008
The intensity of the CK 13, 16-positive staining varied in differ-
ent areas of the same cholesteatoma sample. Specific positive
reaction was not detected in retroauricular skin samples used as
a control. The positive control revealed specific expression of
CK 13 and 16 confined to the islands of neoplastic squamous
cells in laryngeal carcinoma specimens.
DISCUSSION
The putative interactions between major cellular components
of cholesteatoma tissue have been extensively studied in the lit-
eratures. We demonstrate a summarized schematic model of
possible intercellular “cross-talking” between epithelial-mesenchy-
mal components of cholesteatoma in Fig. 7. Both paracrine and
autocrine regulatory mechanisms have been proposed for main-
tenance of tissue homeostasis. Pro-inflammatory cytokines such
as interleukin-1 and interleukin-1 ‚ (IL-1 , IL-1 ) released from
matrix keratinocytes stimulate keratinocytes growth factor
(KGF) expression, which in turn induced proliferation of the
cholesteatoma keratinocytes (10). Granulocyte-macrophage
colony stimulating factor (GM-CSF) is another fibroblasts-
derived growth factor induced by IL-1, with acknowledged
stimulating effects both on proliferation and terminal differentia-
tion of keratinocytes (11). Keratinocytes-derived parathyroid hor-
mone-related protein (PTHrP) induces expression of KGF. KGF
is then released by perimatrix fibroblasts and accelerates the pro-
liferative response in matrix keratinocytes. A possible connec-
tion between PTHrP and bone destructive lesions have also
been reported (12). Transforming growth factor alpha (TGF- ) is
constitutively expressed in keratinocytes and regulates ker-
atinocyte proliferation and differentiation in an autocrine man-
ner (13). On the other hand, a possible synergism between
TGF- and epidermal growth factor (EGF) was proposed with
possible effect on keratinocytes proliferation through epidermal
growth factor receptor (EGF-R), indicating existence of an alter-
native paracrine regulatory mechanism (14). Transforming
growth factor-beta (TGF- ) is expressed in hyperproliferative
epithelium and granulation tissue (15) and influences the epithe-
lial morphogenesis both in an autocrine and paracrine fashion.
The above statements about cellular interactions were taken
into consideration for creating an adequate in vitro middle ear
cholesteatoma model. As it was mentioned before, the prolifer-
ative capacity of primary cholesteatoma keratinocytes in vitro
is limited and expires within 2 passages. To improve their plat-
ing efficiency and survival rate at low density we create a growth-
arrested feeder layer from primary middle ear cholesteatoma
fibroblasts. 3T3-mouse embryo fibroblasts that used routinely
in cell culture practice display different morphological patterns
(cobble-stone morphology), which differs from in vivo state and
complicates result interpretation. Feeder layer secretes nutrients,
growth factors and matrix constituents. As a positive control in
our study we choose HaCaT cell line in order to avoid donor-to-
donor and site-to-site variations in proliferative capacity of nor-
mal skin keratinocytes. HaCaT cells are spontaneously immor-
talized human adult skin keratinocytes raised in reduced calci-
um level and elevated temperature conditions (16). HaCaT found
an extensive application in tissue engineering for development
of artificial skin equivalents (17). The proposed organotypic in
vitro model revealed stronger proliferation and bigger stratifi-
cation, when HaCaT cells were co-cultured with fibroblasts, in
comparison with the control group without fibroblasts. Similar
patterns have been established with primary cholesteatoma ker-
atinocytes. Histopathological diagnosis of cholesteatoma includes:
unrestrained proliferation, uncoordinated differentiation, migra-
tion, and invasion (18). Consistent with the above-mentioned
observation, the proposed 3D-model disclosed disrupted differ-
entiation and presence of nucleated cells in the upper layers of
the cholesteatoma ALI with fibroblasts. The following data cor-
responds to the parakeratotic properties in cholesteatoma tissue
in vivo.
Squamous metaplasia of middle ear epithelium is considered
to be an adaptive tissue response towards persistent pathologi-
cal stimuli such as chronic inflammation and possible etiopatho-
genetical mechanism for middle ear cholesteatoma. An experi-
ment has been reported on the confirmation of a possible trans-
formation of differentiated middle ear epithelium towards func-
tionally inferior multilayered squamous epithelium (19). Epithelial
cells are characterized by the presence of a specific set of inter-
mediate protein filaments named cytokeratins, specific for dif-
ferent epithelial types. One of our primary objectives was to
assess the grade of homogeneity between HaCaT cells and cho-
lesteatoma keratinocyte. CK 16 was suggested in the literature
as a proliferation marker, while CK 13 is considered as a mark-
Fig. 7. Summarized schematic model of putative autocrine and paracrine
regulatory mechanisms, responsible for maintaining of middle ear cho-
lesteatoma tissue homeostasis. IL: interleukin; PTHrP: parathyroid hor-
mone-related protein; TGF: transforming growth factor; KGF: kerati-
nocytes growth factor; EGF: epidermal growth factor; GM-CSF: gran-
ulocyte-macrophage colony stimulating factor.
KGF, EGF
GM-CSF
TGF ,  IL-1
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er of differentiation (20). Immunohistochemical investigation in
our study disclosed non-uniform patterns of expression of CK
13 and CK 16 in middle ear cholesteatoma tissue. Variation in
intensity of the positively stained areas between different cho-
lesteatoma samples as well as between different areas in the
same sample was probably related to the different proliferative
capacity of cholesteatoma. No specific staining was detected in
the retroauricular skin used as a control. The expression of non-
epidermal cytokeratins in middle ear cholesteatoma tissue gives
arguments against the probable skin origin of MECh keratinocytes.
Protein separation and Coomassie blue staining revealed signif-
icantly different protein profile between cholesteatoma and HaCaT
cells. Precised Western-blotting analysis demonstrated compar-
atively stronger expression of CK 13 and 16 in cholesteatoma
keratinocytes with regard to HaCaT cell line. 
CONCLUSIONS
The different protein and cytokeratin profiles established between
cholesteatoma keratinocytes and HaCaT cells favors metaplasia
as a possible cause for development of MECh. The proposed in
vitro model underlines the importance of fibroblasts as a major
component of 3D-in vitro system. Our results emphasize the
integrity of cholesteatoma as a separated pathological tissue,
composed of two closely related functional and structural parts:
the matrix and the perimatrix.
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